
Scopus BioPharma Inc. is a biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need. We are currently focusing our development efforts on our immuno-oncology programs, which are conducted primarily through Duet BioTherapeutics Inc. (... Scopus BioPharma Inc. is a biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need. We are currently focusing our development efforts on our immuno-oncology programs, which are conducted primarily through Duet BioTherapeutics Inc. (Duet), our majority-owned subsidiary. These programs include three distinctive complementary CpG-STAT3 inhibitors: Antisense ("DUET-101"); RNA silencing ("DUET-202"); and DNA-binding inhibitor ("DUET-301"). The Company may also seek to develop additional drug candidates and identify additional compelling technologies for potential acquisition, in-licensing and/or other similar transactions. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.0003 | 0.0003 | 1.0E-6 | 991 | 0.00011722 | CS |
4 | 0 | 0 | 0.0003 | 0.0003 | 1.0E-6 | 729 | 0.00022906 | CS |
12 | 0 | 0 | 0.0003 | 0.0005 | 1.0E-6 | 4564 | 0.00029728 | CS |
26 | 0 | 0 | 0.0003 | 0.01 | 1.0E-6 | 12055 | 0.00031085 | CS |
52 | -0.0017 | -85 | 0.002 | 0.01 | 1.0E-6 | 8390 | 0.00045549 | CS |
156 | -0.0848 | -99.6474735605 | 0.0851 | 0.156 | 1.0E-6 | 23640 | 0.07258344 | CS |
260 | -0.0848 | -99.6474735605 | 0.0851 | 0.156 | 1.0E-6 | 23640 | 0.07258344 | CS |
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관